Rene Aigner1, Juliana Hack2, Daphne Eschbach2, Steffen Ruchholtz2, Matthias Knobe3, Richard Dodel4, Benjamin Buecking2. 1. Center for Orthopaedics and Trauma Surgery, University Hospital Giessen and Marburg GmbH, Baldingerstrasse, 35043, Marburg, Germany. aignerr@med.uni-marburg. 2. Center for Orthopaedics and Trauma Surgery, University Hospital Giessen and Marburg GmbH, Baldingerstrasse, 35043, Marburg, Germany. 3. Department of Trauma and Reconstructive Surgery, University Hospital RWTH Aachen, Aachen, Germany. 4. Department of Neurology, University Hospital Giessen and Marburg, Marburg, Germany.
Abstract
INTRODUCTION: Hip fractures have increased medical and socio-economic importance due to demographic transition. Information concerning direct treatment costs and their reimbursement in Germany is lacking. MATERIALS AND METHODS: Four hundred two hip fracture patients older than 60 years of age were observed prospectively at a German University Hospital. Treatment costs were determined with up to 196 cost factors and compared to the reimbursement. Finally, statistical analysis was performed to identify clinical parameters influencing the cost-reimbursement relation. RESULTS: Treatment costs were 8853 € (95% CI 8297-9410 €), while reimbursement was 8196 € (95% CI 7707-8772 €), resulting in a deficit of 657 € (95% CI 143-1117 €). Bivariate analysis showed that the cost-reimbursement relation was negatively influenced mainly by higher age, higher ASA score, readmission to the intensive care unit (ICU) and red blood cell transfusion. Adjusted for other parameters, readmission to the ICU was a significant negative predictor (- 2669 €; 95% CI - 4070 to - 1268 €; p < 0.001), while age of 60-75 years was a positive predictor for the cost-reimbursement relation (1373 €; 95% CI 265-2480 €; p = 0.015). CONCLUSIONS: Treatment of geriatric hip fracture patients in a university hospital in Germany does not seem to be cost-covering. Adjustment of the reimbursement for treatment of complex hip fracture patients should be considered.
INTRODUCTION:Hip fractures have increased medical and socio-economic importance due to demographic transition. Information concerning direct treatment costs and their reimbursement in Germany is lacking. MATERIALS AND METHODS: Four hundred two hip fracturepatients older than 60 years of age were observed prospectively at a German University Hospital. Treatment costs were determined with up to 196 cost factors and compared to the reimbursement. Finally, statistical analysis was performed to identify clinical parameters influencing the cost-reimbursement relation. RESULTS: Treatment costs were 8853 € (95% CI 8297-9410 €), while reimbursement was 8196 € (95% CI 7707-8772 €), resulting in a deficit of 657 € (95% CI 143-1117 €). Bivariate analysis showed that the cost-reimbursement relation was negatively influenced mainly by higher age, higher ASA score, readmission to the intensive care unit (ICU) and red blood cell transfusion. Adjusted for other parameters, readmission to the ICU was a significant negative predictor (- 2669 €; 95% CI - 4070 to - 1268 €; p < 0.001), while age of 60-75 years was a positive predictor for the cost-reimbursement relation (1373 €; 95% CI 265-2480 €; p = 0.015). CONCLUSIONS: Treatment of geriatric hip fracturepatients in a university hospital in Germany does not seem to be cost-covering. Adjustment of the reimbursement for treatment of complex hip fracturepatients should be considered.
Entities:
Keywords:
Cost-effectiveness; Geriatric fracture; Hip fracture; Ortho-geriatrics; Treatment costs
Authors: Philipp Hemmann; Maximilian Friederich; Daniel Körner; Tim Klopfer; Christian Bahrs Journal: BMC Musculoskelet Disord Date: 2021-05-19 Impact factor: 2.362
Authors: Philipp Hemmann; Maximilian Friederich; Christian Bahrs; Johann Jacoby; Daniel Körner Journal: Arch Orthop Trauma Surg Date: 2021-04-12 Impact factor: 2.928
Authors: Brandon Kelly; Harsh R Parikh; Dylan L McCreary; Logan McMillan; Patrick K Horst; Brian P Cunningham Journal: Geriatr Orthop Surg Rehabil Date: 2020-04-07